Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP992840priorityCriticalpatent/ECSP992840A/en
Publication of ECSP992840ApublicationCriticalpatent/ECSP992840A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Pyridine Compounds
(AREA)
Abstract
Esta invención se refiere a un procedimiento para el tratamiento de un mamífero que presenta insuficiencia cardiaca, que comprende administrar a un mamifero una cantidad terapéuticamente eficaz de 4-(1-etil-propoxi)-3,6-dimeti-2(2,4,6-trimetil-fenoxi)-piridina y (3,6 dimetil-2-(2,4,6 -trimetil-fenoxil-)-piridin-4-il)-(1-etil-propil)-amina o una sal farmacéuticamente aceptable de las mismas. Esta invención también se refiere a procedimientos para usar combinaciones de esos dos agentes con otros compuestos para el tratamiento de la isuficiencia cardiaca congestiva para tratar la insuficiencia cardiaca congestiva.This invention relates to a method of treating a mammal presenting with heart failure, comprising administering to a mammal a therapeutically effective amount of 4- (1-ethyl-propoxy) -3,6-dimethi-2 (2,4 , 6-trimethyl-phenoxy) -pyridine and (3,6-dimethyl-2- (2,4,6 -trimethyl-phenoxy -) - pyridin-4-yl) - (1-ethyl-propyl) -amine or a salt pharmaceutically acceptable thereof. This invention also relates to methods for using combinations of those two agents with other compounds for the treatment of congestive heart failure to treat congestive heart failure.
ECSP9928401999-01-261999-01-26
PROCEDURE TO TREAT HEART FAILURE
ECSP992840A
(en)
APPLICATION OF CYCLOOXIGENASE-2 INHIBITOR, MATRIC METALLOPROTEINASE INHIBITOR, ANTI-TUMOR MEDICINE, AND OPTIONAL IRRADIATION AS A COMBINED METHOD OF TREATING THE NEO.